Toronto Dominion Bank Sells 1,945 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Toronto Dominion Bank reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.0% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 96,735 shares of the company's stock after selling 1,945 shares during the period. Toronto Dominion Bank's holdings in HCA Healthcare were worth $39,316,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of HCA. Meritage Group LP bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $150,548,000. Alpha DNA Investment Management LLC bought a new stake in HCA Healthcare in the third quarter worth $869,000. EP Wealth Advisors LLC lifted its position in shares of HCA Healthcare by 1.6% in the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company's stock worth $72,335,000 after buying an additional 3,516 shares during the last quarter. AustralianSuper Pty Ltd boosted its position in HCA Healthcare by 118.5% during the third quarter. AustralianSuper Pty Ltd now owns 35,493 shares of the company's stock worth $14,425,000 after purchasing an additional 19,247 shares during the period. Finally, Quantinno Capital Management LP grew its stake in HCA Healthcare by 55.9% in the 3rd quarter. Quantinno Capital Management LP now owns 31,750 shares of the company's stock valued at $12,904,000 after buying an additional 11,380 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of research analyst reports. Raymond James lowered HCA Healthcare from an "outperform" rating to a "market perform" rating in a report on Friday, November 22nd. KeyCorp reduced their price objective on HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating for the company in a research report on Monday, October 28th. Morgan Stanley started coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an "equal weight" rating and a $427.00 target price on the stock. Royal Bank of Canada boosted their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research note on Friday, August 23rd. Finally, StockNews.com lowered shares of HCA Healthcare from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $387.13.

HCA Healthcare Trading Down 1.0 %

HCA Healthcare stock traded down $3.14 during trading hours on Thursday, reaching $312.00. 1,568,704 shares of the company's stock traded hands, compared to its average volume of 1,203,520. The firm's 50 day moving average is $358.55 and its 200-day moving average is $358.60. The firm has a market capitalization of $79.03 billion, a price-to-earnings ratio of 14.15, a PEG ratio of 1.23 and a beta of 1.63. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a fifty-two week low of $261.31 and a fifty-two week high of $417.14.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.85%. The ex-dividend date is Friday, December 13th. HCA Healthcare's payout ratio is 11.85%.

Insider Buying and Selling at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the company's stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Phillip G. Billington sold 3,897 shares of the business's stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.